Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Single Day Outdoor Photometric Stereo.

Hold-Geoffroy Y, Gotardo P, Lalonde JF.

IEEE Trans Pattern Anal Mach Intell. 2019 Dec 27. doi: 10.1109/TPAMI.2019.2962693. [Epub ahead of print]

PMID:
31899414
2.

Localization of phosphotyrosine adaptor protein ShcD/SHC4 in the adult rat central nervous system.

Robeson HN, Lau HR, New LA, Lalonde J, Armstrong JN, Jones N.

BMC Neurosci. 2019 Dec 10;20(1):57. doi: 10.1186/s12868-019-0541-5.

3.

Extrapolating from lens design databases using deep learning.

Côté G, Lalonde JF, Thibault S.

Opt Express. 2019 Sep 30;27(20):28279-28292. doi: 10.1364/OE.27.028279.

PMID:
31684583
4.

Aberrant mitochondrial function in patient-derived neural cells from CDKL5 deficiency disorder and Rett syndrome.

Jagtap S, Thanos JM, Fu T, Wang J, Lalonde J, Dial TO, Feiglin A, Chen J, Kohane I, Lee JT, Sheridan SD, Perlis RH.

Hum Mol Genet. 2019 Nov 1;28(21):3625-3636. doi: 10.1093/hmg/ddz208.

5.

Relationship between time-to-isolation and freeze duration: Computational modeling of dosing for Arctic Front Advance and Arctic Front Advance Pro cryoballoons.

Getman MK, Wissner E, Ranjan R, Lalonde JP.

J Cardiovasc Electrophysiol. 2019 Nov;30(11):2274-2282. doi: 10.1111/jce.14150. Epub 2019 Sep 17.

6.

Class I Histone Deacetylase Inhibition by Tianeptinaline Modulates Neuroplasticity and Enhances Memory.

Zhao WN, Ghosh B, Tyler M, Lalonde J, Joseph NF, Kosaric N, Fass DM, Tsai LH, Mazitschek R, Haggarty SJ.

ACS Chem Neurosci. 2018 Sep 19;9(9):2262-2273. doi: 10.1021/acschemneuro.8b00116. Epub 2018 Jun 22.

PMID:
29932631
7.

Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.

Haro JM, Altamura C, Corral R, Elkis H, Evans J, Krebs MO, Zink M, Malla A, Méndez JI, Bernasconi C, Lalonde J, Nordstroem AL.

Psychiatry Res. 2018 Sep;267:56-62. doi: 10.1016/j.psychres.2018.04.005. Epub 2018 Apr 10.

PMID:
29883861
8.

How Many Trigger Fingers Resolve Spontaneously Without Any Treatment?

McKee D, Lalonde J, Lalonde D.

Plast Surg (Oakv). 2018 Feb;26(1):52-54. doi: 10.1177/2292550317740691. Epub 2017 Nov 21.

9.

Chemogenomic analysis reveals key role for lysine acetylation in regulating Arc stability.

Lalonde J, Reis SA, Sivakumaran S, Holland CS, Wesseling H, Sauld JF, Alural B, Zhao WN, Steen JA, Haggarty SJ.

Nat Commun. 2017 Nov 21;8(1):1659. doi: 10.1038/s41467-017-01750-7.

10.

αII Spectrin Forms a Periodic Cytoskeleton at the Axon Initial Segment and Is Required for Nervous System Function.

Huang CY, Zhang C, Ho TS, Oses-Prieto J, Burlingame AL, Lalonde J, Noebels JL, Leterrier C, Rasband MN.

J Neurosci. 2017 Nov 22;37(47):11311-11322. doi: 10.1523/JNEUROSCI.2112-17.2017. Epub 2017 Oct 16.

11.

Deep 6-DOF Tracking.

Garon M, Lalonde JF.

IEEE Trans Vis Comput Graph. 2017 Nov;23(11):2410-2418. doi: 10.1109/TVCG.2017.2734599. Epub 2017 Aug 10.

PMID:
28809698
12.

Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells.

Iaconelli J, Lalonde J, Watmuff B, Liu B, Mazitschek R, Haggarty SJ, Karmacharya R.

ACS Chem Biol. 2017 Aug 18;12(8):2139-2148. doi: 10.1021/acschembio.6b01014. Epub 2017 Jul 10.

13.

Effects of anandamide administration on components of reward processing during free choice.

Zona LC, Fry BR, LaLonde JA, Cromwell HC.

Pharmacol Biochem Behav. 2017 Jul;158:14-21. doi: 10.1016/j.pbb.2017.05.008. Epub 2017 May 18.

PMID:
28529018
14.

Effect of Lymphedema Treatment for Management of Acute Pilon Fractures.

Whatley JM, Lalonde JA, Greene CC, Riche KB, Tatum DM.

Orthopedics. 2017 Jul 1;40(4):e668-e674. doi: 10.3928/01477447-20170509-02. Epub 2017 May 15.

PMID:
28504809
15.

Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.

Tobe BTD, Crain AM, Winquist AM, Calabrese B, Makihara H, Zhao WN, Lalonde J, Nakamura H, Konopaske G, Sidor M, Pernia CD, Yamashita N, Wada M, Inoue Y, Nakamura F, Sheridan SD, Logan RW, Brandel M, Wu D, Hunsberger J, Dorsett L, Duerr C, Basa RCB, McCarthy MJ, Udeshi ND, Mertins P, Carr SA, Rouleau GA, Mastrangelo L, Li J, Gutierrez GJ, Brill LM, Venizelos N, Chen G, Nye JS, Manji H, Price JH, McClung CA, Akiskal HS, Alda M, Chuang DM, Coyle JT, Liu Y, Teng YD, Ohshima T, Mikoshiba K, Sidman RL, Halpain S, Haggarty SJ, Goshima Y, Snyder EY.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4462-E4471. doi: 10.1073/pnas.1700111114. Epub 2017 May 12.

16.

Burden of illness of people with persistent symptoms of schizophrenia: A multinational cross-sectional study.

Nordstroem AL, Talbot D, Bernasconi C, Berardo CG, Lalonde J.

Int J Soc Psychiatry. 2017 Mar;63(2):139-150. doi: 10.1177/0020764016688040. Epub 2017 Jan 29.

PMID:
28134026
17.

Highly engineered biocatalysts for efficient small molecule pharmaceutical synthesis.

Lalonde J.

Curr Opin Biotechnol. 2016 Dec;42:152-158. doi: 10.1016/j.copbio.2016.04.023. Epub 2016 Jun 1. Review.

PMID:
27261887
18.

Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition.

Melillo B, Liang S, Park J, Schön A, Courter JR, LaLonde JM, Wendler DJ, Princiotto AM, Seaman MS, Freire E, Sodroski J, Madani N, Hendrickson WA, Smith AB 3rd.

ACS Med Chem Lett. 2016 Jan 19;7(3):330-4. doi: 10.1021/acsmedchemlett.5b00471. eCollection 2016 Mar 10.

19.

Canadian Stroke Best Practice Recommendations: Acute Inpatient Stroke Care Guidelines, Update 2015.

Casaubon LK, Boulanger JM, Glasser E, Blacquiere D, Boucher S, Brown K, Goddard T, Gordon J, Horton M, Lalonde J, LaRivière C, Lavoie P, Leslie P, McNeill J, Menon BK, Moses B, Penn M, Perry J, Snieder E, Tymianski D, Foley N, Smith EE, Gubitz G, Hill MD, Lindsay P; Heart and Stroke Foundation of Canada Canadian Stroke Best Practices Advisory Committee.

Int J Stroke. 2016 Feb;11(2):239-52. doi: 10.1177/1747493015622461. No abstract available.

PMID:
26783316
20.

O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1.

Malachowski WP, Winters M, DuHadaway JB, Lewis-Ballester A, Badir S, Wai J, Rahman M, Sheikh E, LaLonde JM, Yeh SR, Prendergast GC, Muller AJ.

Eur J Med Chem. 2016 Jan 27;108:564-576. doi: 10.1016/j.ejmech.2015.12.028. Epub 2015 Dec 17.

21.

Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study.

Haro JM, Altamura C, Corral R, Elkis H, Evans J, Malla A, Krebs MO, Zink M, Bernasconi C, Lalonde J, Nordstroem AL.

Schizophr Res. 2015 Dec;169(1-3):234-240. doi: 10.1016/j.schres.2015.09.001. Epub 2015 Oct 1.

PMID:
26431792
22.

Canadian Stroke Best Practice Recommendations: Hyperacute Stroke Care Guidelines, Update 2015.

Casaubon LK, Boulanger JM, Blacquiere D, Boucher S, Brown K, Goddard T, Gordon J, Horton M, Lalonde J, LaRivière C, Lavoie P, Leslie P, McNeill J, Menon BK, Moses B, Penn M, Perry J, Snieder E, Tymianski D, Foley N, Smith EE, Gubitz G, Hill MD, Glasser E, Lindsay P; Heart and Stroke Foundation of Canada Canadian Stroke Best Practices Advisory Committee.

Int J Stroke. 2015 Aug;10(6):924-40. doi: 10.1111/ijs.12551. Epub 2015 Jul 6.

PMID:
26148019
23.

Noncoding RNAs connect genetic risk factors to the neurodevelopmental basis of bipolar disorder.

Bavamian S, Mellios N, Lalonde J, Fass DM, Wang J, Sheridan SD, Madison JM, Zhou F, Rueckert EH, Barker D, Perlis RH, Sur M, Haggarty SJ.

Mol Psychiatry. 2015 May;20(5):548. doi: 10.1038/mp.2015.51. No abstract available.

24.

The feasibility of using electronic clinical outcome assessments in people with schizophrenia and their informal caregivers.

Tolley C, Rofail D, Gater A, Lalonde JK.

Patient Relat Outcome Meas. 2015 Mar 26;6:91-101. doi: 10.2147/PROM.S79348. eCollection 2015.

25.

Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder.

Bavamian S, Mellios N, Lalonde J, Fass DM, Wang J, Sheridan SD, Madison JM, Zhou F, Rueckert EH, Barker D, Perlis RH, Sur M, Haggarty SJ.

Mol Psychiatry. 2015 May;20(5):573-84. doi: 10.1038/mp.2014.176. Epub 2015 Jan 27.

26.

Engineered calcium-precipitable restriction enzyme.

Hendrix J, Read T, Lalonde JF, Jensen PK, Heymann W, Lovelace E, Zimmermann SA, Brasino M, Rokicki J, Dowell RD.

ACS Synth Biol. 2014 Dec 19;3(12):969-71. doi: 10.1021/sb500042m.

PMID:
25524101
27.

Directed evolution of an ultrastable carbonic anhydrase for highly efficient carbon capture from flue gas.

Alvizo O, Nguyen LJ, Savile CK, Bresson JA, Lakhapatri SL, Solis EO, Fox RJ, Broering JM, Benoit MR, Zimmerman SA, Novick SJ, Liang J, Lalonde JJ.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16436-41. doi: 10.1073/pnas.1411461111. Epub 2014 Nov 3.

28.

Store-operated calcium entry promotes the degradation of the transcription factor Sp4 in resting neurons.

Lalonde J, Saia G, Gill G.

Sci Signal. 2014 Jun 3;7(328):ra51. doi: 10.1126/scisignal.2005242.

29.

Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options.

Chue P, Lalonde JK.

Neuropsychiatr Dis Treat. 2014 May 8;10:777-89. doi: 10.2147/NDT.S43404. eCollection 2014. Review.

30.

CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.

Madani N, Princiotto AM, Schön A, LaLonde J, Feng Y, Freire E, Park J, Courter JR, Jones DM, Robinson J, Liao HX, Moody MA, Permar S, Haynes B, Smith AB 3rd, Wyatt R, Sodroski J.

J Virol. 2014 Jun;88(12):6542-55. doi: 10.1128/JVI.00540-14. Epub 2014 Apr 2.

31.

Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.

Courter JR, Madani N, Sodroski J, Schön A, Freire E, Kwong PD, Hendrickson WA, Chaiken IM, LaLonde JM, Smith AB 3rd.

Acc Chem Res. 2014 Apr 15;47(4):1228-37. doi: 10.1021/ar4002735. Epub 2014 Feb 6. Review.

32.

Crystal structures of HIV-1 gp120 envelope glycoprotein in complex with NBD analogues that target the CD4-binding site.

Kwon YD, LaLonde JM, Yang Y, Elban MA, Sugawara A, Courter JR, Jones DM, Smith AB 3rd, Debnath AK, Kwong PD.

PLoS One. 2014 Jan 28;9(1):e85940. doi: 10.1371/journal.pone.0085940. eCollection 2014.

33.

Phosphorylation of the transcription factor Sp4 is reduced by NMDA receptor signaling.

Saia G, Lalonde J, Sun X, Ramos B, Gill G.

J Neurochem. 2014 May;129(4):743-52. doi: 10.1111/jnc.12657. Epub 2014 Feb 12.

34.

The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1.

Flick HE, Lalonde JM, Malachowski WP, Muller AJ.

Int J Tryptophan Res. 2013 Aug 19;6:35-45. doi: 10.4137/IJTR.S12094. eCollection 2013.

35.

Teaching medical students and residents how to inject local anesthesia almost painlessly.

Farhangkhoee H, Lalonde J, Lalonde DH.

Can J Plast Surg. 2012 Fall;20(3):169-72.

36.

Structure-Based Design and Synthesis of an HIV-1 Entry Inhibitor Exploiting X-Ray and Thermodynamic Characterization.

Lalonde JM, Le-Khac M, Jones DM, Courter JR, Park J, Schön A, Princiotto AM, Wu X, Mascola JR, Freire E, Sodroski J, Madani N, Hendrickson WA, Smith AB 3rd.

ACS Med Chem Lett. 2013 Mar 14;4(3):338-343.

37.

A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption.

Emileh A, Tuzer F, Yeh H, Umashankara M, Moreira DR, Lalonde JM, Bewley CA, Abrams CF, Chaiken IM.

Biochemistry. 2013 Apr 2;52(13):2245-61. doi: 10.1021/bi400166b. Epub 2013 Mar 22.

38.

Wide-awake trapeziectomy: video detailing local anesthetic injection and surgery.

Farhangkhoee H, Lalonde J, Lalonde DH.

Hand (N Y). 2011 Dec;6(4):466-7. doi: 10.1007/s11552-011-9367-z. Epub 2011 Sep 24.

39.

HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism.

Tuzer F, Madani N, Kamanna K, Zentner I, LaLonde J, Holmes A, Upton E, Rajagopal S, McFadden K, Contarino M, Sodroski J, Chaiken I.

Proteins. 2013 Feb;81(2):271-90. doi: 10.1002/prot.24184. Epub 2012 Oct 26.

40.

Spontaneous rearrangement of the β20/β21 strands in simulations of unliganded HIV-1 glycoprotein, gp120.

Shrivastava IH, Wendel K, LaLonde JM.

Biochemistry. 2012 Oct 2;51(39):7783-93. doi: 10.1021/bi300878d. Epub 2012 Sep 21.

41.

Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors.

LaLonde JM, Kwon YD, Jones DM, Sun AW, Courter JR, Soeta T, Kobayashi T, Princiotto AM, Wu X, Schön A, Freire E, Kwong PD, Mascola JR, Sodroski J, Madani N, Smith AB 3rd.

J Med Chem. 2012 May 10;55(9):4382-96. doi: 10.1021/jm300265j. Epub 2012 Apr 23.

42.

Efficient, chemoenzymatic process for manufacture of the Boceprevir bicyclic [3.1.0]proline intermediate based on amine oxidase-catalyzed desymmetrization.

Li T, Liang J, Ambrogelly A, Brennan T, Gloor G, Huisman G, Lalonde J, Lekhal A, Mijts B, Muley S, Newman L, Tobin M, Wong G, Zaks A, Zhang X.

J Am Chem Soc. 2012 Apr 11;134(14):6467-72. doi: 10.1021/ja3010495. Epub 2012 Mar 28.

PMID:
22409428
43.

Is main operating room sterility really necessary in carpal tunnel surgery? A multicenter prospective study of minor procedure room field sterility surgery.

Leblanc MR, Lalonde DH, Thoma A, Bell M, Wells N, Allen M, Chang P, McKee D, Lalonde J.

Hand (N Y). 2011 Mar;6(1):60-3. doi: 10.1007/s11552-010-9301-9. Epub 2010 Nov 18.

44.

By how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder?

Hudson JI, Coit CE, Lalonde JK, Pope HG Jr.

Int J Eat Disord. 2012 Jan;45(1):139-41. doi: 10.1002/eat.20890. Epub 2010 Dec 10.

PMID:
22170026
45.

The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium.

Pinacho R, Villalmanzo N, Lalonde J, Haro JM, Meana JJ, Gill G, Ramos B.

Bipolar Disord. 2011 Aug-Sep;13(5-6):474-85. doi: 10.1111/j.1399-5618.2011.00941.x.

46.

Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry.

Acharya P, Dogo-Isonagie C, LaLonde JM, Lam SN, Leslie GJ, Louder MK, Frye LL, Debnath AK, Greenwood JR, Luongo TS, Martin L, Watts KS, Hoxie JA, Mascola JR, Bewley CA, Kwong PD.

ACS Chem Biol. 2011 Oct 21;6(10):1069-77. doi: 10.1021/cb200068b. Epub 2011 Aug 5.

47.

Biotechnology for the acceleration of carbon dioxide capture and sequestration.

Savile CK, Lalonde JJ.

Curr Opin Biotechnol. 2011 Dec;22(6):818-23. doi: 10.1016/j.copbio.2011.06.006. Epub 2011 Jul 5. Review.

PMID:
21737251
48.

Enhanced dynamics of HIV gp120 glycoprotein by small molecule binding.

Shrivastava I, LaLonde JM.

Biochemistry. 2011 May 17;50(19):4173-83. doi: 10.1021/bi2002218. Epub 2011 Apr 21.

49.

[Pointe-de-l'Ile CSSS. An occupational health promotion laboratory].

Beaudet N, Lalonde J.

Perspect Infirm. 2011 Mar-Apr;8(2):46-8. French. No abstract available.

PMID:
21462540
50.

Some binding-related drug properties are dependent on thermodynamic signature.

Schön A, Madani N, Smith AB, Lalonde JM, Freire E.

Chem Biol Drug Des. 2011 Mar;77(3):161-5. doi: 10.1111/j.1747-0285.2010.01075.x. Epub 2011 Feb 2.

Supplemental Content

Loading ...
Support Center